Bank Of New York Mellon Corp Soma Logic, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $1.11 Million - $1.88 Million	540,806 New	540,806 $1.36 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $3,030 - $26,310	-4,810 Reduced 0.87%	551,197 $1.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $1.82 Million - $3.52 Million	425,924 Added 327.42%	556,007 $2.51 Million
Q1 2022 May 11, 2022	BUY	$7.07 - $11.62 $9,070 - $14,908	1,283 Added 1.0%	130,083 $1.04 Million
Q4 2021 Feb 11, 2022	BUY	$10.49 - $14.28 $778,504 - $1.06 Million	74,214 Added 135.96%	128,800 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$9.94 - $12.77 $542,584 - $697,063	54,586 New	54,586 $676,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.